Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04344652

Photoscreening for Retinoblastoma

Prospective Evaluation of a Smartphone Application, GoCheckKids TM, as a Screening Tool for Leukocoria in the Infant and Pediatric Population

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Phoenix Children's Hospital · Academic / Other
Sex
All
Age
0 Years – 10 Years
Healthy volunteers
Accepted

Summary

Retinoblastoma is the most common pediatric eye malignancy and manifests between 1 and 5 years of age. The tumor is most often diagnosed by leukocoria ( white reflex in the pupil). There is often a significant delay in diagnosis and early diagnosis enables good life prognosis and better vision outcome.There is currently not a standardized screening protocol for detection of retinoblastoma. Vision screening methods are recommended for children 3-5 years of age. The investigators are attempting to use instrument based screening started from birth to detect leukocoria.

Conditions

Interventions

TypeNameDescription
DEVICEPhotoscreening -external picture taken with a an phone based app

Timeline

Start date
2022-06-01
Primary completion
2022-06-01
Completion
2022-06-01
First posted
2020-04-14
Last updated
2025-09-26

Source: ClinicalTrials.gov record NCT04344652. Inclusion in this directory is not an endorsement.

Photoscreening for Retinoblastoma (NCT04344652) · Clinical Trials Directory